Aimovig is a brand name for the medicine Erenumab, also known as erenumab-aooe. Sometimes the suffix is included to distinguish the drug from possible future products of similar drugs. It is a monoclonal antibody, a medication made from immune system cells in a laboratory.

• Aimovig must be injected subcutaneously under the skin in areas like the upper arm, thigh, or abdomen.
• Never inject this drug into the areas of the skin that is bruised, red, or painful.
• It is given once every month on or about the same day each month, and the doctor teaches the patients to do it by themselves.
• Administer the erenumab-aooe injection as prescribed. Use it only as the doctor directs, neither more nor less than that.
• Always take the medication on schedule and never more often than advised.

• Injection-site pain, redness, or itching.
• Muscle cramps.
• Constipation.
• Rashes.
• Itching.
• Face, lip, eye, or tongue swelling.
• Trouble swallowing.
• Breathing difficulties.
• Chest ache.

• Dry natural rubber is a latex derivative in the needle shield inside the prefilled autoinjector’s white cap, and the prefilled syringe’s gray needle cap may cause allergic responses in those sensitive to latex.
• This medicine has a risk of fatal hypersensitivity reactions like angioedema and anaphylaxis, demanding immediate medical attention.
• When combined with other medications that slow down bowel movement, erenumab-aooe may raise a person’s risk of experiencing severe constipation.
• People with high blood pressure should use this medication cautiously as it may worsen their condition.